AGP
DGX icon

Artia Global Partners’s Quest Diagnostics DGX Stock Holding History

Artia Global Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
65,122
+24,305
+60% +$4.77M 2.55% 13
2026
Q1 		$8M Hold
40,817
– – 1.6% 14
2025
Q4 		$7.08M Sell
40,817
-40,900
-50% -$7.45M 1% 18
2025
Q3 		$15.6M Hold
81,717
– – 2.47% 15
2025
Q2 		$14.7M Buy
81,717
+25,000
+44% +$4.34M 3.53% 8
2025
Q1 		$9.6M Buy
+56,717
New +$9.32M 2.43% 13

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Artia Global Partners's DGX Position: Q2 2026 in Review

Artia Global Partners increased its Quest Diagnostics (DGX) stake by 60% in Q2 2026, buying an estimated $4.77M and bringing the position to 65,122 shares worth $13.8M. The position accounts for 2.55% of the portfolio, ranked #13.

Artia Global Partners first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.6M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Artia Global Partners held 65,122 shares of Quest Diagnostics worth $13.8M as of Q2 2026.
  • Artia Global Partners bought 24,305 Quest Diagnostics shares in Q2 2026, an estimated $4.77M.
  • Quest Diagnostics made up 2.55% of Artia Global Partners's portfolio in Q2 2026, its #13 holding.
  • Artia Global Partners first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • Artia Global Partners's Quest Diagnostics position peaked at $15.6M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.